Endocytosis of abiotic nanomaterials and nanobiovectors: Inhibition of membrane trafficking

P Makvandi, M Chen, R Sartorius, A Zarrabi… - Nano Today, 2021 - Elsevier
Humans are exposed to nanoscopical nanobiovectors (eg coronavirus SARS-CoV-2) as
well as abiotic metal/carbon-based nanomaterials that enter cells serendipitously or …

Nanoparticle entry into cells; the cell biology weak link

G Griffiths, J Gruenberg, M Marsh, J Wohlmann… - Advanced Drug Delivery …, 2022 - Elsevier
Nanoparticles (NP) are attractive options for the therapeutic delivery of active
pharmaceutical drugs, proteins and nucleic acids into cells, tissues and organs. Research …

Corneal epithelial findings in patients with multiple myeloma treated with antibody–drug conjugate belantamab mafodotin in the pivotal, randomized, DREAMM-2 …

AV Farooq, S Degli Esposti, R Popat, P Thulasi… - Ophthalmology and …, 2020 - Springer
Introduction Patients with relapsed or refractory multiple myeloma (RRMM) represent an
unmet clinical need. Belantamab mafodotin (belamaf; GSK2857916) is a first-in-class …

[HTML][HTML] Macrophage membrane-biomimetic adhesive polycaprolactone nanocamptothecin for improving cancer-targeting efficiency and impairing metastasis

K Ying, Y Zhu, J Wan, C Zhan, Y Wang, B Xie, P Xu… - Bioactive materials, 2023 - Elsevier
The recent remarkable success and safety of mRNA lipid nanoparticle technology for
producing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines has …

Biological and intracellular fates of drug nanocrystals through different delivery routes: Recent development enabled by bioimaging and PK modeling

Y Lv, W Wu, CD Corpstein, T Li, Y Lu - Advanced Drug Delivery Reviews, 2022 - Elsevier
Abstract Nanocrystals have contributed to exciting improvements in the delivery of poorly
water-soluble drugs. The biological and intracellular fates of nanocrystals are currently …

Recent progress of solid lipid nanoparticles and nanostructured lipid carriers as ocular drug delivery platforms

V Gugleva, V Andonova - Pharmaceuticals, 2023 - mdpi.com
Sufficient ocular bioavailability is often considered a challenge by the researchers, due to
the complex structure of the eye and its protective physiological mechanisms. In addition, the …

[HTML][HTML] R11 modified tumor cell membrane nanovesicle-camouflaged nanoparticles with enhanced targeting and mucus-penetrating efficiency for intravesical …

B Zheng, Z Liu, H Wang, L Sun, WF Lai, H Zhang… - Journal of Controlled …, 2022 - Elsevier
Intravesical chemotherapy is generally used in the clinic for treating bladder cancer (BCa),
but its efficacy is limited due to the permeation barrier and side effects caused by the off …

[HTML][HTML] Lipid-based nanoparticles: Enhanced cellular uptake via surface thiolation

P Knoll, GF Racaniello, V Laquintana, F Veider… - International Journal of …, 2023 - Elsevier
The aim of this study was to evaluate the uptake mechanism of thiolated nanostructured lipid
carriers (NLCs). NLCs were decorated with a short-chain polyoxyethylene (10) stearyl ether …

[HTML][HTML] Lentinan-functionalized selenium nanoparticles target tumor cell mitochondria via TLR4/TRAF3/MFN1 pathway

HJ Liu, Y Qin, ZH Zhao, Y Zhang, JH Yang, DH Zhai… - Theranostics, 2020 - ncbi.nlm.nih.gov
Rationale: Malignant ascites caused by cancer cells results in poor prognosis and short
average survival time. No effective treatment is currently available for malignant ascites. In …

Potential therapeutic usage of nanomedicine for glaucoma treatment

S Kwon, SH Kim, D Khang, JY Lee - International Journal of …, 2020 - Taylor & Francis
Glaucoma is a group of diseases characterized by progressive degeneration of retinal
ganglion cells, leading to irreversible blindness. Currently, intraocular pressure reduction is …